BiotechTube
Home/TearSolutions/Marc G. Odrich, MD
MG

Marc G. Odrich, MD

Chief Medical Officer / Medical Director

TearSolutions

Therapeutic Areas

OphthalmologyOcular Surface Disease

TearSolutions Pipeline

DrugIndicationPhase
LacripepOcular Surface Disease / Dry Eye Disease (Primary Sjögren's Syndrome)Phase 2

Leadership Team at TearSolutions

AC
Anil C. Asrani
President / CEO
GW
Gordon W. Laurie, PhD FARVO
Chief Scientific Officer / Co-founder
JN
James N. Cook
Chief Development Officer
CM
Colin M. Rolph
Chief Financial Officer
View full TearSolutions profile